Anavex Life Sciences Corp (AVXL)

[Anshu2]

1. AVXL thinks it has approval (AA) worthy biomarker data.

2. Data hasn’t been released,

3. It has been one year since trial completion.

Wow. What to make out of the above facts? My theories on potential facts that may explain the above:

1. AVXL has good biomarker data — but far from being approval worthy. So, it’s just spinning it (eg finding the right threshold can take time).

2. AVXL is extremely slow and clueless — doesn’t understand the implications of slowness. So, even though it has/may have great data, it’s taking its sweet time.

3. We are being impatient; it indeed takes 1-2 years to get the biomarker data out.

Take your pick.